Features of immune mediated diseases in JAK2 (V617F)-positive myeloproliferative neoplasms and the potential therapeutic role of JAK inhibitors
-
Published:2023-12
Issue:
Volume:
Page:
-
ISSN:0953-6205
-
Container-title:European Journal of Internal Medicine
-
language:en
-
Short-container-title:European Journal of Internal Medicine
Author:
Álvarez-Reguera CarmenORCID,
Prieto-Peña DianaORCID,
Herrero-Morant AlbaORCID,
Sánchez-Bilbao Lara,
Batlle-López Ana,
Fernández-Luis Sara,
Paz-Gandiaga Nerea,
Blanco RicardoORCID
Subject
Internal Medicine